2000
DOI: 10.1006/phrs.2000.0733
|View full text |Cite
|
Sign up to set email alerts
|

Subtype identification and functional properties of inositol 1,4,5-trisphosphate receptors in heart and aorta

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
4
1

Year Published

2002
2002
2011
2011

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 12 publications
(5 citation statements)
references
References 39 publications
0
4
1
Order By: Relevance
“…More importantly, tetracaine appeared to mediate its action by altering Ca 2ϩ signaling and Ca 2ϩ sensitization. In other studies, tetracaine has been suggested to block IP 3 -mediated Ca 2ϩ release at high concentrations (1 mM) (36,51). However, we found that 50 M tetracaine does not affect Ca 2ϩ release in response to IP 3 .…”
Section: Discussioncontrasting
confidence: 78%
“…More importantly, tetracaine appeared to mediate its action by altering Ca 2ϩ signaling and Ca 2ϩ sensitization. In other studies, tetracaine has been suggested to block IP 3 -mediated Ca 2ϩ release at high concentrations (1 mM) (36,51). However, we found that 50 M tetracaine does not affect Ca 2ϩ release in response to IP 3 .…”
Section: Discussioncontrasting
confidence: 78%
“…These results suggest that Ca 2ϩ released from IP 3 Rs following submaximal agonist stimulation may open neighboring RyRs and then induce further Ca 2ϩ release from the SR (CICR), which amplifies agonist-induced increase in [Ca 2ϩ ] i and contraction in PASMCs. Since it has been reported that RyR antagonists may inhibit IP 3 Rs directly or indirectly (Vites and Pappano, 1992;Yamazawa et al, 1992;Iino et al, 1994;Tovey et al, 2000;Zimmermann, 2000;Flynn et al, 2001), one might argue that the inhibition of IP 3 Rs could account for the effects of the RyR antagonists on noradrenaline-induced Ca 2ϩ release and contraction in PASMCs. However, our data and previous reports indicate that this may not be the case in pulmonary artery (vascular) SMCS.…”
Section: Discussionmentioning
confidence: 99%
“…Since RyR antagonists have been reported to inhibit IP 3 Rs directly or indirectly (Vites and Pappano, 1992;Yamazawa et al, 1992;Iino et al, 1994;Tovey et al, 2000;Zimmermann, 2000;Flynn et al, 2001), we sought to examine the specificity of the RyR antagonists on neurotransmitter-induced Ca 2ϩ release in cultured human PASMCs, since these cells lack functional expression of RyRs (Fig. 3).…”
Section: Ryanodine Receptors Amplify Submaximal Neurotransmitterinduced Ca 2ϩ Release and Contraction In Pasmcsmentioning
confidence: 99%
“…64 All incubations and experiments were carried out at room temperature (23.51C). Imaging was performed by transferring a single glass coverslip into a perfusion chamber mounted on a Zeiss 135 inverted microscope equipped with a 100 W mercury arc lamp (RatioArc; Atto Instruments).…”
Section: Calcium Imagingmentioning
confidence: 99%